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Wiskott–Aldrich Syndrome: Immunodeﬁciency resulting from defective cell
migration and impaired immunostimulatory activation
Gerben Boumaa,, Siobhan O. Burnsa,b, Adrian J. Thrashera,b,1
aCentre for Immunodeficiency, Molecular Immunology, UCL Institute of Child Health, Molecular Immunology, 30 Guilford Street,
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Regulation of the actin cytoskeleton is crucial for many aspects of correct and cooperative functioning of immune
cells, such as migration, antigen uptake and cell activation. The Wiskott–Aldrich Syndrome protein (WASp) is an
important regulator of actin cytoskeletal rearrangements and lack of this protein results in impaired immune function.
This review discusses recent new insights of the role of WASp at molecular and cellular level and evaluates how WASp
deﬁciency affects important immunological features and how defective immune cell function contributes to
compromised host defence.
r 2009 Elsevier GmbH. Open access under CC BY license.
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The actin cytoskeleton regulates many cellular func-
tions that are related to the immune response, such as
migration, extravasation, antigen uptake and recogni-
tion, and cell activation. An important regulator of the
actin cytoskeleton is the Wiskott–Aldrich Syndrome
protein (WASp) and patients who lack its expression
have compromised immune function. Here we discuss at
molecular and cellular level how WASp deﬁciency
affects important immunological features, such as
migration and cell activation, and how defective
immune cell functioning contributes to a compromised
host defence.Importance of the actin cytoskeleton for immune
responses
Effective immunity is dependent on correct and
cooperative function of all immune cell lineages. While
the innate arm of the immune system is important in the
ﬁrst stages of infection, the adaptive arm is required to
maintain long-term protection and memory. Both cells
of the innate and of the adaptive arms require dynamic
cytoskeletal rearrangements to allow effective cellular
function. Recruitment of innate blood-borne neutro-
phils and monocytes to inﬂammatory sites is dependent
on dynamic cell shape changes to allow the cells
to diapedese from the blood stream, through the
vascular endothelium into the underlying tissue (Vicente-
Manzanares and Sanchez-Madrid 2004; Worthylake and
Burridge 2001). Several steps are involved in this process
of tethering, rolling and extravasation, and the actin
cytoskeleton plays an important role in all of these
individual steps. At the inﬂammatory site, phagocytosis
of particulate antigens and uptake of soluble antigens
through endocytosis/pinocytosis by neutrophils and
macrophages requires protrusion and retraction of the
plasma membrane, which is regulated by the actin
cytoskeleton (Swanson 2008). Uptake of antigens by
dendritic cells (DCs) in an inﬂammatory environment
initiates maturation and migration of DC to the draining
lymphoid tissues, where they present the captured
antigen to T cells (Banchereau and Steinman 1998).
Dynamic cytoskeletal rearrangement is mandatory for
DC motility and for formation of the immunological
synapse (IS) during T cell priming (Al-Alwan et al. 2001;
Vicente-Manzanares and Sanchez-Madrid 2004). PrimedT cells subsequently home to the inﬂammatory site to
assist macrophages in the clearance of pathogens or to
exert effector function such as killing of virus-infected
cells by cytotoxic T cells. Again, for these processes a
functional and dynamic cytoskeletal rearrangement
machinery is essential (Vicente-Manzanares and Sanchez-
Madrid 2004; Worthylake and Burridge 2001).Defective cytoskeletal rearrangements lead to
Wiskott–Aldrich Syndrome
The Wiskott–Aldrich Syndrome protein is a key
regulator of the actin cytoskeleton, transmitting and
integrating actin-regulating signals that are essential for
multiple cell functions, including cell motility and
induction of cell shape change (Burns et al. 2004a;
Thrasher 2002). Reduced or absent WASp expression
may result in the primary immunodeﬁciency disorder
Wiskott–Aldrich Syndrome (WAS), which is character-
ized by a classical triad of microthrombocytopenia,
eczema and immune deﬁciency, affecting 1–10 in
1 000 000 live births (Ochs and Thrasher 2006).
The WAS gene is localised on the X chromosome and
encodes the 502-amino-acid-long WASp. As WASp is
exclusively expressed in haematopoietic cells, defective
function has been described in most immune cell
lineages, giving rise to a complex combined cellular
and humoral immune deﬁciency, resulting in suscept-
ibility to severe and life-threatening infections (Ochs and
Thrasher 2006). Defective immunological function can
include generalised lymphopenia, abnormal T cell
proliferation (especially in response to CD3 stimulation)
and aberrant immunoglobulin responses to protein and
more particularly to polysaccharide antigens, including
reduced isohaemagglutinin levels (Ochs et al. 1980;
Sullivan et al. 1994; Park et al. 2004). In addition, failure
of immunity may manifest as autoimmunity, which was
seen in 40% and 72% of WAS patients in two
independent studies (Dupuis-Girod et al. 2003; Sullivan
et al. 1994). A wide range of autoimmune diseases can
occur even as early as infancy, with autoimmune
cytopenias, arthritis and vasculitis being the most
common complications. While relatively understudied,
recently new insights into the pathophysiology of WAS
autoimmune features are emerging and several reports
have shown defective suppressor function of regulatory
T cells in WAS (Adriani et al. 2007; Humblet-Baron
et al. 2007; Maillard et al. 2007; Marangoni et al. 2007).
Clinically, WAS-related autoimmunity can be difﬁcult
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Girod et al. 2003; Imai et al. 2004). Haematopoietic
malignancies are an additional serious complication of
WAS, which may result from defective immune surveil-
lance, although the pathogenic mechanisms are pre-
sently unclear (Burns et al. 2004a; Shcherbina et al.
1999; Imai et al. 2004). Approximately 300 unique
mutations in the WAS gene have been reported with
ﬁve speciﬁc mutations occurring with high frequency
(Jin et al. 2004; Notarangelo et al. 2005; Imai et al.
2003). Three of these mutations give rise to a milder
clinical phenotype, which is mainly restricted to micro-
thrombocytopenia and is referred to as X-linked
thrombocytopenia (XLT; Jin et al. 2004; Ochs and
Thrasher 2006). Intriguingly, mutations that give rise to
constitutively active WASp result in a completely
different clinical phenotype, characterised by congenital
neutropenia and severe bacterial infections (Ancliff et al.
2006; Devriendt et al. 2001). Studies of the effects of
WASp deﬁciency in vivo have been assisted by the
generation of two separate WASp knockout (WAS KO)
mouse models, both of which provide good mimics for
the haematopoietic features of human WAS (Snapper
et al. 1998; Zhang et al. 1999).
On the whole, XLT has a good prognosis with
conservative treatment, although recent long-term studies
suggest that the incidence of autoimmunity may be higher
than previously thought (Imai et al. 2004). In contrast
severely affected WAS patients have poor prognosis
without treatment, with bleeding and severe infections
constituting the major causes of morbidity and mortality
in infancy and early childhood. The only curative therapy,
at present, is bone marrow or haematopoietic stem cell
transplantation. In the last decade good progress has been
made in the development of corrective gene therapy for
WAS. Many reports have shown that good expression of
WASp and functional restoration of lymphocytes could
be achieved, initially using gammaretroviral transdcution
(Candotti et al. 1999; Dupre et al. 2004; Strom et al.
2003a; Wada et al. 2002) and more recently by lentiviral
transduction (Charrier et al. 2007; Dupre et al. 2004;
Martin et al. 2005). Furthermore, studies with WAS KO
mice have demonstrated that gene therapy allows safe and
long-term restoration of WASp expression and function-
ality in multiple immune cell lineages (Blundell et al. 2008;
Charrier et al. 2005; Dupre et al. 2006; Frecha et al. 2008;
Klein et al. 2003; Martin et al. 2005; Strom et al. 2003b).
Gene therapy trials in human patients have recently been
initiated (Notarangelo et al. 2005; Ochs and Thrasher
2006).Cytoskeletal rearrangements by WASp
WASp is a member of a family of proteins regulating
cytoskeletal rearrangements. Other WASp family homo-logues are more widely expressed than WASp itself and
in vertebrates these include ubiquitously expressed
neural WASp (N-WASp) and three homologues of
WASP family Verprolin-homologous protein (WAVE),
also called suppressor of G-protein coupled cyclic-AMP
receptor (SCAR; Takenawa and Suetsugu 2007). All
family members are multi-domain proteins identiﬁed by
sequence homology and binding interactions that serve
to integrate signals for regulating WASp activity and
sub-cellular localisation. The closest sequence homology
is shared with N-WASp and common domains in these
proteins have similar binding partners and functions.
All WASp family proteins contain a characteristic
C-terminal VCA domain (verprolin homology, central
and acidic domain) capable of activating the actin-
related protein (Arp)2/3 complex to initiate formation of
new actin ﬁlaments. Cytosolic WASp adopts an auto-
inhibited conformation in which the VCA domain is
associated with the proximal GTPase binding domain
(GBD; Kim et al. 2000). Binding of the GTPase Cdc42
via a complex with Toca-1 results in disruption of the
autoinhibited conformation, which releases the VCA
domain and allows Arp2/3 and actin monomer binding
(Buck et al. 2001; Ho et al. 2004; Lim et al. 2007).
WASp-bound Arp2/3 complex is then able to mediate
new actin polymerization, driving the assembly of a
branched network of actin ﬁlaments and providing the
mechanical propulsion for membrane protrusion, cell
motility and cell shape changes (Millard et al. 2004).
Another mechanism for WASp activation is provided
by phosphorylation, and has been described to occur in
a variety of stimuli, including T cell receptor (TCR)
stimulation, IgE receptor stimulation on mast cells and
collagen receptor stimulation on platelets (Badour et al.
2004; Gross et al. 1999; Guinamard et al. 1998; Millard
et al. 2004; Oda et al. 1998). An important residue for
phosphorylation is tyrosine Y291, described as a target
for Btk and Src family kinases (Badour et al. 2004; Cory
et al. 2002; Guinamard et al. 1998; Torres and Rosen
2003, 2005). It is suggested that phosphorylation of
tyrosine 291 lowers the threshold for Cdc42 activation
and stabilises the ‘open’ molecular conformation of
WASp (Torres and Rosen 2003, 2005), although there is
also evidence that tyrosine 291 phosphorylation occurs
independently of Cdc42 activation (Badour et al. 2004;
Cory et al. 2002). Mutating tyrosine 291 to mimick its
phosphorylated state renders WASp constitutively
active and results in enhanced actin polymerization,
demonstrating a direct effect of WASp phosphorylation
on its function (Cory et al. 2002). All three constitutively
active mutations found in patients with X-linked
neutropenia are located in the GBD. They have been
described to result in enhanced actin polymerization and
dysregulated cell division, emphasising the importance
of tightly regulated WASp activity (Ancliff et al. 2006;
Devriendt et al. 2001; Moulding et al. 2007).
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immunodeﬁciency
A hallmark of WAS is defective migration of immune
cells, which is likely to be a major contributor to the
observed immune dysfunction.Granulocytes
Granulocytes form the host’s ﬁrst line of defence
against invading pathogens with neutrophils being
amongst the ﬁrst cells to respond. Migration of neutro-
phils is impaired in WAS KO mice both in vitro and in
vivo (Snapper et al. 2005; Zhang et al. 2006), but human
data are conﬂicting. While granulocytes isolated from
patients with WAS demonstrated normal chemotaxis
towards fMLP (Zicha et al. 1998), migration in response
to c5a was shown to be impaired (Ochs et al. 1980).
Defects in adhesion and migration of neutrophils in WAS
appear to be subtle and more evident under conditions of
physiologic shear ﬂow, during which integrin attachment
is critical, suggesting that ‘outside-in’ integrin signalling is
defective in WASp deﬁciency (Zhang et al. 2006).Monocytes, macrophages and DCs
As with neutrophils, monocytes exit the circulation to
enter inﬂamed tissues, where they can differentiate into
macrophages or DC (Tacke and Randolph 2006).
Monocytes, macrophages and DC from WAS patients
are all defective in their ability to polarise and migrate in
response to inﬂammatory chemokines in vitro (Altman
et al. 1974; Badolato et al. 1998; Binks et al. 1998; Burns
et al. 2001; Jones et al. 2002; Zicha et al. 1998). In vivo
migration of murine DC is also impaired by WASp
deﬁciency as shown by decreased migration of skin-
resident DC and adoptively transferred DC to draining
lymph nodes (Bouma et al. 2007; de Noronha et al.
2005; Snapper et al. 2005) and dyslocalisation of DC to
the T cell areas of spleen or lymph nodes (Bouma et al.
2007; de Noronha et al. 2005). Contact of migrating
myeloid cells with the substratum is thought to be
mediated by podosomes, which are actin-rich structures
that are surrounded by a ring of integrins and integrin-
associated proteins. They are localised close to the
leading edge of the cells and are important for cellular
migration (Linder and Kopp 2005). WASp-deﬁcient
macrophages and DC display a striking lack of
podosomes (Burns et al. 2001, 2004b; Calle et al. 2004;
Jones et al. 2002; Linder et al. 1999). Down-regulation
of WASp expression using lentiviral vector-mediated
RNA interference induces identical morphological and
migratory defects in DC from healthy individuals (Olivier
et al. 2006), indicating a direct role for WASp inmediating the cytoskeletal defects that are observed in
WASp-deﬁcient cells. Restoration of WASp expression by
gene replacement signiﬁcantly restores podosome defects
and improves the migratory ability in macrophages and
DC both in vitro and in vivo (Blundell et al. 2008; Burns
et al. 2001; Charrier et al. 2005; Jones et al. 2002).
Lymphocytes
T and B lymphocytes of WAS patients and WAS KO
mice have been shown to be impaired in their migratory
capacity (Gallego et al. 2005; Snapper et al. 2005;
Westerberg et al. 2005). While thymic T cell develop-
ment appears to be relatively normal in WAS KO mice
(Cotta-de-Almeida et al. 2007; Snapper et al. 1998;
Zhang et al. 1999), reduced number of circulating T cells
are found in WAS KO mice (Snapper et al. 1998) as well
as WAS patients (Ochs et al. 1980; Park et al. 2004).
However it remains to be investigated whether this is the
resultant of reduced migratory potential or decreased
survival. WASp-deﬁcient B cells fail to migrate towards
CXCL13 (Westerberg et al. 2005) and T cells do not
respond to CCL19 and CCL21 (Snapper et al. 2005).
Abnormal splenic architecture has been reported in both
patients and mice, where both T cell areas and B cell
follicles appear less well developed (Andreansky et al.
2005; de Noronha et al. 2005; Gerwin et al. 1996; Vermi
et al. 1999; Westerberg et al. 2005). It is likely that
impaired B and T cell migration is a contributing factor
to the depleted white pulp of WAS spleen as the
chemokine CXCL13 is thought to be crucial for
attracting B cells to the lymphoid follicles (Ansel et al.
2000) and CCL19 and CCL21 mediate T cell homing to
the T cell area of secondary lymphoid tissue (Gunn et al.
1999). Reduced homing potential of regulatory T cells,
in addition to defective suppressor function, has recently
been described, which could provide an explanation for
the reduced number of peripheral regulatory T cells
observed in WAS patients and WAS KOmice (Humblet-
Baron et al. 2007; Maillard et al. 2007).Cell migration is important for initiating
immune responses
The efﬁcacy of an immune response is dependent on
both the spatial and temporal distribution of immune
cells. Impaired migration of immune cells is likely to
affect the mounting of an immune response in several
aspects (Fig. 1). Firstly, impaired recruitment of
neutrophils, monocytes and DC to inﬂammatory sites
will allow longer time for pathogens to replicate and
induce damage. Secondly, impaired migration of DC to
draining lymphoid tissue will delay priming of antigen-
speciﬁc T cells. This process is further hindered by
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Fig. 1. Schematic representation of regulation of WASp activity. Cytosolic WASp exists in an autoinhibited conformation in which
the VCA domain is bound to the GBD (A). Activation of WASp by the Cdc42-GTP/Toca-1 complex or by phosphorylation of
tyrosine 291 disrupts the autoinhibited conformation, enabling Arp2/3 binding and actin polymerization (B).
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and DC. Thirdly, defective DC migration results in
dyslocalisation of DC to the T cell area in lymphoid
tissues such as spleen and lymph nodes, thus reducing
the efﬁcacy of encountering and activating antigen-
speciﬁc T cells. And fourthly, defective migration of T
cells means that homing of effector T cells to the
inﬂammatory site will be reduced or delayed, further
obstructing the ongoing immune response. It is clear
that impaired migratory potential of immune cells is a
signiﬁcant contributor to dysregulated cellular localisa-
tion and a likely contributor to immunodeﬁciency.WASp deﬁciency affects immune cell effector
function
In addition to a general defect of immune cell
migration, effector function of most immune cells is
affected by WASp deﬁciency.Cells of the innate immune system
The ability to phagocytose is a key aspect of cells of
the innate arm of the immune system. Phagocytosis is
mediated by the formation of actin-based membrane
invaginations, called phagocytic cups, that enclose extra-cellular particles and subsequently internalise these into
so-called phagosomes (Swanson 2008). Monocytes of
WAS patients are impaired in the uptake of FITC-
labelled Escherichia coli (Lorenzi et al. 2000) and also
macrophages show decreased phagocytosis of apoptotic
cells and latex beads associated with defective phagocytic
cup formation (Leverrier et al. 2001; Lorenzi et al. 2000)
(Fig. 2). While granulocyte-mediated phagocytosis has
not been investigated in WAS patients, this function is
defective in WAS KO murine neutrophils (Zhang
et al. 1999). WAS KO DCs have also been shown to be
defective in their phagocytic capacity, although uptake of
soluble antigens was normal (Westerberg et al. 2003).
Knockdown of WASp by means of RNA interference
conﬁrmed the importance of WASp in mediating
phagocytosis and phagocytic cup formation (Tsuboi and
Meerloo 2007).
Only a few studies have been reported that investigate
NK cell function in WAS. NK cells appear to have
impaired lytic activity (Gismondi et al. 2004; Messina
et al. 1986; Orange et al. 2002), which is most likely due
to defective synapse formation with target cells (Orange
et al. 2002) (Fig. 2).
Cells of the adaptive immune system
Several cytoskeletal defects of WASp-deﬁcient lym-
phocytes have been described, including reduced actin
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CD4+ T cells. See text for references.
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and spreading and formation of membrane protrusions
(Andreu et al. 2007; Facchetti et al. 1998; Molina et al.
1992, 1993; Westerberg et al. 2001, 2005). Proliferation
in response to anti-IgM-mediated B cell receptor
activation and in response to T cell receptor ligation
are both impaired, while proliferation in response to
mitogenic stimuli is unaffected (Gallego et al. 1997;
Henriquez et al. 1994; Molina et al. 1993; Snapper et al.
1998; Zhang et al. 1999). Restoration of WASp
expression by retroviral or lentiviral gene therapy has
been shown to signiﬁcantly improve T cell proliferation
(Charrier et al. 2005, 2007; Dupre et al. 2004, 2006;
Klein et al. 2003; Strom et al. 2003a, 2003b; Wada et al.
2002).
WASp-deﬁcient CD4+ and CD8+ T cells fail to
produce Th1 cytokines upon TCR activation (Fig. 2),
which persists when T cells are cultured in Th1-
polarising conditions (Morales-Tirado et al. 2004;
Trifari et al. 2006). Interestingly, secretion of chemo-
kines was normal (Morales-Tirado et al. 2004) and
secretion of Th2 cytokines was only minimally affected
(Trifari et al. 2006). It remains uncertain whether this is
a speciﬁc defect for human WAS T cells, as in WAS KOmice, cytokine responses appeared normal (Nguyen
et al. 2007). Memory T cell responses, however, were
found to be impaired in WAS KO mice in response to
inﬂuenza A virus (Andreansky et al. 2005; Strom et al.
2003b), although the role of priming by APC was not
addressed in these studies.
Recently several reports have demonstrated impaired
function of WASp-deﬁcient regulatory T cells (Adriani
et al. 2007; Humblet-Baron et al. 2007; Maillard et al.
2007; Marangoni et al. 2007). Although there does not
seem to be consensus on whether regulatory T cell
numbers in thymus and periphery are normal or
reduced, it is clear that function of regulatory T cells
both in vitro and in vivo is impaired.
There is a striking reduction in the number of
marginal zone B cells in WAS KO mice (Meyer-
Bahlburg et al. 2008; Westerberg et al. 2005, 2008) and
of postgerminal CD27+ B cells, the human equivalent of
marginal zone B cells, in WAS patients (Park et al.
2005), which is likely associated with the reduced
antibody response to polysaccharide antigens (Ochs
et al. 1980). Development of B cells appears normal with
the exception of mature B cell subsets, in particular
marginal zone B cells (Meyer-Bahlburg et al. 2008;
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impaired migration of B cell is a contributing factor in
this defect.WASp in the immunological synapse
A major focus of research into the pathophysiology of
WAS has been the role of WASp in TCR signalling.
Formation of the immunological synapse at the inter-
face between APC and T cells is required for optimal
and appropriate T cell activation. Classically the IS is
deﬁned as a dynamic molecular structure formed around
a central cluster of TCRs bound to peptide-loaded
MHC molecules on the T cell and DC side, respectively.
This central cluster is usually referred to as the central
(c) supramolecular activation cluster (SMAC). LFA-1-
ICAM-1 interactions and talin form a ring around the
cSMAC and are referred to as peripheral (p) SMAC
(Dustin et al. 2006; Monks et al. 1998). The IS ensures
optimal T cell activation, although T cell activation can
also occur in the absence of cSMAC formation (Lee
et al. 2003). The cSMAC has been implicated as a site
for receptor degradation (Varma et al. 2006), indicating
that in order for the IS to be maintained, continuous
signalling and recruitment of molecules is required.
WASp-deﬁcient T cells display a well-documented
defect of proliferation and IL-2 production in response
to TCR stimulation (Cannon and Burkhardt 2004;
Dupre et al. 2002; Gallego et al. 1997; Molina et al.
1993; Snapper et al. 1998; Zhang et al. 1999) (Fig. 2).Directly after TCR stimulation WASp is recruited to
lipid rafts (Dupre et al. 2002), which are required for IS
formation (Dykstra et al. 2003). In the absence of
WASp, T cells failed to aggregate lipid rafts to the
synapse site (Dupre et al. 2002). Targeting WASp to the
IS is likely to be mediated by its polyproline domain, as
a mutated WASp in which the polyproline domain was
deleted failed to localise to the IS, in contrast to a GBD-
deleted WASp mutant (Badour et al. 2003; Cannon et al.
2001). Several adaptor molecules have been implicated
in mediating WASp activation and recruitment to the
IS (Fig. 3). TCR signalling induces accumulation of
ZAP-70 to lipid rafts and subsequently to the IS
(Sasahara et al. 2002). ZAP-70 and Lck recruitment
has been shown to be instrumental for the accumulation
of Cdc42-GTP to the synapse and leads to phosphor-
ylation of the adaptor molecule Slp-76 (Zeng et al.
2003). Slp-76 has been proposed to recruit WASp
through binding to the SH-3 domain of Nck on one
hand, while on the other hand it recruits the GTPase
Vav-1, which mediates activation of Cdc42 and subse-
quently activation of WASp (Zeng et al. 2003).
Although Cdc42 is an important activator of WASp,
its role may be redundant in WASp activation at the IS
(Cannon et al. 2001). Activation of WASp at the IS has
also been shown to be mediated by the Fyn kinase,
which binds the polyproline domain of WASp via its
SH3 domain and phosphorylates tyrosine 291 (Fig. 3)
(Badour et al. 2004). This activational mechanism was
independent of Cdc42-mediated WASp activation and
potentially regulated by dephosphorylation of Y291 by
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PSTPIP1 and could be recruited to the synapse by CD2
(Badour et al. 2003, 2004). A further role for WASp has
been implicated in regulating dynamics of the IS by Sims
et al. (2007), who showed that although the IS was
initially formed in WASp-deﬁcient T cells, symmetry of
the pSMAC was lacking, resulting in disruption and
failure of the IS to re-form.
Most of these studies have been performed using B
cell–T cell conjugates, but interestingly when EL4
thymoma cells or lipid bilayers were used as antigen-
presenting cells no defects were observed in the ability
of the WASp null T cells to form conjugates (Krawczyk
et al. 2002; Sims et al. 2007). It has been suggested that
defective synapse formation in WASp-deﬁcient T cells is
dependent on antigen dose (Cannon and Burkhardt
2004) and differences in MHC:TCR afﬁnity could
explain why normal conjugates were formed when using
AND, P14 or DO11.10 TCR transgenic WASp null T
cells, but not when using OTII TCR transgenic WASp
null cells (Badour et al. 2003, 2004; Cannon et al. 2001;
Cannon and Burkhardt 2004; Krawczyk et al. 2002;
Sims et al. 2007).DC regulation of immunological synapse
formation
Recent ﬁndings have indicated that interaction of
WAS KO DC with normal T cells resulted in reduced
antigen-speciﬁc CD4+ and CD8+ T lymphocyte pro-
liferation (Bouma et al. 2007; Pulecio et al. 2008).
Although impaired migration of DC contributes to
reduced T cell responses, the direct interaction between
DC and T cells is also hampered (Fig. 2). In vitro studies,
which eliminate migration as confounder, have shown
that priming of WASp-sufﬁcient T cells by antigen-
loaded WASp-deﬁcient DC is indeed reduced (Bouma
et al. 2007) and correcting the reduced number of DC
that reach the lymph nodes in vivo did not rescue
defective T cell priming by WAS KO DC (Pulecio et al.
2008). In addition, WASp-expressing T cells failed to
form stable contacts with WASp null DC either in vitro
or in vivo (Pulecio et al. 2008), suggesting that DC-
mediated IS formation could be defective. A similar
defect has been reported previously, when it was shown
that WASp null DC fail to form an immunostimulatory
synapse with wild-type NK cells (Borg et al. 2004).
These data suggest that WASp-deﬁcient DC will fail to
form a stable, functional IS with T cells, although this
remains to be formally investigated. There is ample
evidence that IS formation is impaired in WASp-
deﬁcient T cells (Badour et al. 2003, 2004; Cannon
et al. 2001; Cannon and Burkhardt 2004; Dupre et al.
2002; Sasahara et al. 2002; Zeng et al. 2003), and it is
highly likely that when both DC and T cells lack WASp,the quality and function of the IS will be further
reduced. Indeed, an important role for the APC in the
formation of the IS is suggested by the ﬁndings that
defects in IS formation could be rescued by modulating
afﬁnity of TCR–MHC interactions through antigen
dose or varying choice of APC or TCR (Badour et al.
2003, 2004; Cannon et al. 2001; Cannon and Burkhardt
2004; Krawczyk et al. 2002; Sims et al. 2007). Recently,
it was reported that WASp-deﬁcient B cells fail to
accumulate LFA-1 molecules to the pSMAC and fail to
form a mature IS (Meyer-Bahlburg et al. 2008),
suggesting that in addition to DC, B cell APC function
may be deﬁcient as well. Given the defective suppressor
function of regulatory T cells in WAS, it would be very
interesting to investigate whether defective regulatory T
cell function is the result of improper APC activation, as
was shown for WASp-deﬁcient DC activation of CD4+
and CD8+ T cells (Bouma et al. 2007; Pulecio et al. 2008).Concluding remarks
Taken together there is compelling evidence that
migration of most immune cell lineages is defective as a
result of lack of WASp expression. This most likely has
a signiﬁcant impact on the efﬁcacy of immune cells to
reach sites of infection and to transport antigens to
draining secondary lymphoid tissue. Furthermore,
activation of T cells is impaired. This is probably due
to reduced proliferative capacity of the T cells them-
selves on the one hand and to defective IS formation on
the other hand. It is becoming clear that WASp is
involved not only at the T cell side of the IS but also in
the APC. We would like to speculate that WASp
deﬁciency in the APC is an important factor in defective
IS formation, resulting in defective T cell education, but
this needs further investigation. Taken together, reduced
migration and defective activation of immune cells will
impair, or at least delay, the mounting of an immune
response, resulting in compromised immunity.Acknowledgements
This work was supported by grants from the
Wellcome Trust (057965/Z/99/B; A.J.T. and G.B.) and
the European Union (040855, WASpTrafﬁcDC; G.B.).
S.O.B. was sponsored by the Primary Immunodeﬁciency
Association, the Academy of Medical Sciences, and the
Institute of Child Health, University College London.References
Adriani, M., Aoki, J., Horai, R., Thornton, A.M., Konno, A.,
Kirby, M., Anderson, S.M., Siegel, R.M., Candotti, F.,
ARTICLE IN PRESS
G. Bouma et al. / Immunobiology 214 (2009) 778–790786Schwartzberg, P.L., 2007. Impaired in vitro regulatory T
cell function associated with Wiskott–Aldrich syndrome.
Clin. Immunol.
Al-Alwan, M.M., Rowden, G., Lee, T.D., West, K.A., 2001.
The dendritic cell cytoskeleton is critical for the formation
of the immunological synapse. J. Immunol. 166, 1452–1456.
Altman, L.C., Snyderman, R., Blaese, R.M., 1974. Abnorm-
alities of chemotactic lymphokine synthesis and mono-
nuclear leukocyte chemotaxis in Wiskott–Aldrich
syndrome. J. Clin. Invest. 54, 486–493.
Ancliff, P.J., Blundell, M.P., Cory, G.O., Calle, Y., Worth, A.,
Kempski, H., Burns, S., Jones, G.E., Sinclair, J., Kinnon,
C., Hann, I.M., Gale, R.E., Linch, D.C., Thrasher, A.J.,
2006. Two novel activating mutations in the Wiskott–Al-
drich syndrome protein result in congenital neutropenia.
Blood 108, 2182–2189.
Andreansky, S., Liu, H., Turner, S., McCullers, J.A., Lang, R.,
Rutschman, R., Doherty, P.C., Murray, P.J., Nienhuis,
A.W., Strom, T.S., 2005. WASP-mice exhibit defective
immune responses to inﬂuenza A virus, Streptococcus
pneumoniae, and Mycobacterium bovis BCG. Exp. Hema-
tol. 33, 443–451.
Andreu, N., Aran, J.M., Fillat, C., 2007. Novel membrane cell
projection defects in Wiskott–Aldrich syndrome B cells.
Int. J. Mol. Med. 20, 445–450.
Ansel, K.M., Ngo, V.N., Hyman, P.L., Luther, S.A., Forster,
R., Sedgwick, J.D., Browning, J.L., Lipp, M., Cyster, J.G.,
2000. A chemokine-driven positive feedback loop organizes
lymphoid follicles. Nature 406, 309–314.
Badolato, R., Sozzani, S., Malacarne, F., Bresciani, S., Fiorini,
M., Borsatti, A., Albertini, A., Mantovani, A., Ugazio,
A.G., Notarangelo, L.D., 1998. Monocytes from Wiskot-
t–Aldrich patients display reduced chemotaxis and lack of
cell polarization in response to monocyte chemoattractant
protein-1 and formyl-methionyl-leucyl-phenylalanine.
J. Immunol. 161, 1026–1033.
Badour, K., Zhang, J., Shi, F., Leng, Y., Collins, M.,
Siminovitch, K.A., 2004. Fyn and PTP-PEST-mediated
regulation of Wiskott–Aldrich Syndrome protein (WASp)
tyrosine phosphorylation is required for coupling T cell
antigen receptor engagement to WASp effector function
and T cell activation. J. Exp. Med. 199, 99–112.
Badour, K., Zhang, J., Shi, F., McGavin, M.K., Rampersad,
V., Hardy, L.A., Field, D., Siminovitch, K.A., 2003. The
Wiskott–Aldrich syndrome protein acts downstream of
CD2 and the CD2AP and PSTPIP1 adaptors to promote
formation of the immunological synapse. Immunity 18,
141–154.
Banchereau, J., Steinman, R.M., 1998. Dendritic cells and the
control of immunity. Nature 392, 245–252.
Binks, M., Jones, G.E., Brickell, P.M., Kinnon, C., Katz,
D.R., Thrasher, A.J., 1998. Intrinsic dendritic cell abnorm-
alities in Wiskott–Aldrich syndrome. Eur. J. Immunol. 28,
3259–3267.
Blundell, M.P., Bouma, G., Calle, Y., Jones, G.E., Kinnon, C.,
Thrasher, A.J., 2008. Improvement of migratory defects in
a murine model of Wiskott–Aldrich syndrome gene
therapy. Mol. Ther. 16, 836–844.
Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi,
H., Charrier, S., Ryffel, B., Cambi, A., Figdor, C.,Vainchenker, W., Galy, A., Caignard, A., Zitvogel, L.,
2004. NK cell activation by dendritic cells (DCs) requires
the formation of a synapse leading to IL-12 polarization in
DCs. Blood 104, 3267–3275.
Bouma, G., Burns, S., Thrasher, A.J., 2007. Impaired T cell
priming in vivo resulting from dysfunction of WASp-
deﬁcient dendritic cells. Blood 110, 4278–4284.
Buck, M., Xu, W., Rosen, M.K., 2001. Global disruption of
the WASP autoinhibited structure on Cdc42 binding.
Ligand displacement as a novel method for monitoring
amide hydrogen exchange. Biochemistry 40, 14115–14122.
Burns, S., Cory, G.O., Vainchenker, W., Thrasher, A.J.,
2004a. Mechanisms of WASp-mediated hematologic and
immunologic disease. Blood 104, 3454–3462.
Burns, S., Hardy, S.J., Buddle, J., Yong, K.L., Jones, G.E.,
Thrasher, A.J., 2004b. Maturation of DC is associated with
changes in motile characteristics and adherence. Cell Motil.
Cytoskeleton 57, 118–132.
Burns, S., Thrasher, A.J., Blundell, M.P., Machesky, L., Jones,
G.E., 2001. Conﬁguration of human dendritic cell cytoske-
leton by Rho GTPases, the WAS protein, and differentia-
tion. Blood 98, 1142–1149.
Calle, Y., Jones, G.E., Jagger, C., Fuller, K., Blundell, M.P.,
Chow, J., Chambers, T., Thrasher, A.J., 2004. WASp
deﬁciency in mice results in failure to form osteoclast
sealing zones and defects in bone resorption. Blood 103,
3552–3561.
Candotti, F., Facchetti, F., Blanzuoli, L., Stewart, D.M.,
Nelson, D.L., Blaese, R.M., 1999. Retrovirus-mediated
WASP gene transfer corrects defective actin polymerization
in B cell lines from Wiskott–Aldrich syndrome patients
carrying ‘null’ mutations. Gene Ther. 6, 1170–1174.
Cannon, J.L., Burkhardt, J.K., 2004. Differential roles for
Wiskott–Aldrich syndrome protein in immune synapse
formation and IL-2 production. J. Immunol. 173,
1658–1662.
Cannon, J.L., Labno, C.M., Bosco, G., Seth, A., McGavin,
M.H., Siminovitch, K.A., Rosen, M.K., Burkhardt, J.K.,
2001. Wasp recruitment to the T cell:APC contact site
occurs independently of Cdc42 activation. Immunity 15,
249–259.
Charrier, S., Dupre, L., Scaramuzza, S., Jeanson-Leh, L.,
Blundell, M.P., Danos, O., Cattaneo, F., Aiuti, A.,
Eckenberg, R., Thrasher, A.J., Roncarolo, M.G., Galy,
A., 2007. Lentiviral vectors targeting WASp expression to
hematopoietic cells, efﬁciently transduce and correct cells
from WAS patients. Gene Ther. 14, 415–428.
Charrier, S., Stockholm, D., Seye, K., Opolon, P., Taveau, M.,
Gross, D.A., Bucher-Laurent, S., Delenda, C., Vainchen-
ker, W., Danos, O., Galy, A., 2005. A lentiviral vector
encoding the human Wiskott–Aldrich syndrome protein
corrects immune and cytoskeletal defects in WASP knock-
out mice. Gene Ther. 12, 597–606.
Cory, G.O., Garg, R., Cramer, R., Ridley, A.J., 2002.
Phosphorylation of tyrosine 291 enhances the ability of
WASp to stimulate actin polymerization and ﬁlopodium
formation. Wiskott- Aldrich Syndrome protein. J. Biol.
Chem. 277, 45115–45121.
Cotta-de-Almeida, V., Westerberg, L., Maillard, M.H.,
Onaldi, D., Wachtel, H., Meelu, P., Chung, U.I., Xavier,
ARTICLE IN PRESS
G. Bouma et al. / Immunobiology 214 (2009) 778–790 787R., Alt, F.W., Snapper, S.B., 2007. Wiskott Aldrich
syndrome protein (WASP) and N-WASP are critical for
T cell development. Proc. Natl. Acad. Sci. USA 104,
15424–15429.
de Noronha, S., Hardy, S., Sinclair, J., Blundell, M.P., Strid,
J., Schulz, O., Zwirner, J., Jones, G.E., Katz, D.R.,
Kinnon, C., Thrasher, A.J., 2005. Impaired dendritic-cell
homing in vivo in the absence of Wiskott–Aldrich
syndrome protein. Blood 105, 1590–1597.
Devriendt, K., Kim, A.S., Mathijs, G., Frints, S.G., Schwartz,
M., Van Den Oord, J.J., Verhoef, G.E., Boogaerts, M.A.,
Fryns, J.P., You, D., Rosen, M.K., Vandenberghe, P.,
2001. Constitutively activating mutation in WASP causes
X-linked severe congenital neutropenia. Nat. Genet. 27,
313–317.
Dupre, L., Aiuti, A., Trifari, S., Martino, S., Saracco, P.,
Bordignon, C., Roncarolo, M.G., 2002. Wiskott–Aldrich
syndrome protein regulates lipid raft dynamics during
immunological synapse formation. Immunity 17, 157–166.
Dupre, L., Marangoni, F., Scaramuzza, S., Trifari, S.,
Hernandez, R.J., Aiuti, A., Naldini, L., Roncarolo, M.G.,
2006. Efﬁcacy of gene therapy for Wiskott–Aldrich
syndrome using a WAS promoter/cDNA-containing lenti-
viral vector and nonlethal irradiation. Hum. Gene Ther. 17,
303–313.
Dupre, L., Trifari, S., Follenzi, A., Marangoni, F., Lain, dL.,
Bernad, A., Martino, S., Tsuchiya, S., Bordignon, C.,
Naldini, L., Aiuti, A., Roncarolo, M.G., 2004. Lentiviral
vector-mediated gene transfer in T cells from Wiskott–
Aldrich syndrome patients leads to functional correction.
Mol. Ther. 10, 903–915.
Dupuis-Girod, S., Medioni, J., Haddad, E., Quartier, P.,
Cavazzana-Calvo, M., Le Deist, F., de Saint, B.G.,
Delaunay, J., Schwarz, K., Casanova, J.L., Blanche, S.,
Fischer, A., 2003. Autoimmunity in Wiskott–Aldrich
syndrome: risk factors, clinical features, and outcome in a
single-center cohort of 55 patients. Pediatrics 111,
e622–e627.
Dustin, M.L., Tseng, S.Y., Varma, R., Campi, G., 2006. T cell-
dendritic cell immunological synapses. Curr. Opin. Im-
munol. 18, 512–516.
Dykstra, M., Cherukuri, A., Sohn, H.W., Tzeng, S.J., Pierce,
S.K., 2003. Location is everything: lipid rafts and immune
cell signaling. Annu. Rev. Immunol. 21, 457–481.
Facchetti, F., Blanzuoli, L., Vermi, W., Notarangelo, L.D.,
Giliani, S., Fiorini, M., Fasth, A., Stewart, D.M., Nelson,
D.L., 1998. Defective actin polymerization in EBV-trans-
formed B-cell lines from patients with the Wiskott–Aldrich
syndrome. J. Pathol. 185, 99–107.
Frecha, C., Toscano, M.G., Costa, C., Saez-Lara, M.J.,
Cosset, F.L., Verhoeyen, E., Martin, F., 2008. Improved
lentiviral vectors for Wiskott–Aldrich syndrome gene
therapy mimic endogenous expression proﬁles throughout
haematopoiesis. Gene Ther. 15, 930–941.
Gallego, M.D., de la Fuente, M.A., Anton, I.M., Snapper, S.,
Fuhlbrigge, R., Geha, R.S., 2005. WIP and WASP play
complementary roles in T cell homing and chemotaxis to
SDF-1{alpha}. Int. Immunol. 18, 221–232.
Gallego, M.D., Santamaria, M., Pena, J., Molina, I.J., 1997.
Defective actin reorganization and polymerization ofWiskott–Aldrich T cells in response to CD3-mediated
stimulation. Blood 90, 3089–3097.
Gerwin, N., Friedrich, C., Perez-Atayde, A., Rosen, F.S.,
Gutierrez-Ramos, J.C., 1996. Multiple antigens are altered
on T and B lymphocytes from peripheral blood and spleen
of patients with Wiskott–Aldrich syndrome. Clin. Exp.
Immunol. 106, 208–217.
Gismondi, A., Cifaldi, L., Mazza, C., Giliani, S., Parolini, S.,
Morrone, S., Jacobelli, J., Bandiera, E., Notarangelo, L.,
Santoni, A., 2004. Impaired natural and CD16-mediated
NK cell cytotoxicity in patients with WAS and XLT: ability
of IL-2 to correct NK cell functional defect. Blood 104,
436–443.
Gross, B.S., Wilde, J.I., Quek, L., Chapel, H., Nelson, D.L.,
Watson, S.P., 1999. Regulation and function of WASp in
platelets by the collagen receptor, glycoprotein VI. Blood
94, 4166–4176.
Guinamard, R., Aspenstrom, P., Fougereau, M., Chavrier, P.,
Guillemot, J.C., 1998. Tyrosine phosphorylation of the
Wiskott–Aldrich syndrome protein by Lyn and Btk is
regulated by CDC42. FEBS Lett. 434, 431–436.
Gunn, M.D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa,
A., Williams, L.T., Nakano, H., 1999. Mice lacking
expression of secondary lymphoid organ chemokine have
defects in lymphocyte homing and dendritic cell localiza-
tion. J. Exp. Med. 189, 451–460.
Henriquez, N.V., Rijkers, G.T., Zegers, B.J., 1994. Antigen
receptor-mediated transmembrane signaling in Wiskott–
Aldrich syndrome. J. Immunol. 153, 395–399.
Ho, H.Y., Rohatgi, R., Lebensohn, A.M., Le, M., Li, J., Gygi,
S.P., Kirschner, M.W., 2004. Toca-1 mediates Cdc42-
dependent actin nucleation by activating the N-WASP–
WIP complex. Cell 118, 203–216.
Humblet-Baron, S., Sather, B., Anover, S., Becker-Herman,
S., Kasprowicz, D.J., Khim, S., Nguyen, T., Hudkins-Loya,
K., Alpers, C.E., Ziegler, S.F., Ochs, H., Torgerson, T.,
Campbell, D.J., Rawlings, D.J., 2007. Wiskott–Aldrich
syndrome protein is required for regulatory T cell home-
ostasis. J. Clin. Invest. 117, 407–418.
Imai, K., Morio, T., Zhu, Y., Jin, Y., Itoh, S., Kajiwara, M.,
Yata, J., Mizutani, S., Ochs, H.D., Nonoyama, S., 2004.
Clinical course of patients with WASP gene mutations.
Blood 103, 456–464.
Imai, K., Nonoyama, S., Ochs, H.D., 2003. WASP (Wiskott–
Aldrich syndrome protein) gene mutations and phenotype.
Curr. Opin. Allergy Clin. Immunol. 3, 427–436.
Jin, Y., Mazza, C., Christie, J.R., Giliani, S., Fiorini, M.,
Mella, P., Gandellini, F., Stewart, D.M., Zhu, Q., Nelson,
D.L., Notarangelo, L.D., Ochs, H.D., 2004. Mutations of
the Wiskott–Aldrich Syndrome Protein (WASP): hotspots,
effect on transcription, and translation and phenotype/
genotype correlation. Blood 104, 4010–4019.
Jones, G.E., Zicha, D., Dunn, G.A., Blundell, M., Thrasher, A.,
2002. Restoration of podosomes and chemotaxis in Wiskot-
t–Aldrich syndrome macrophages following induced expres-
sion of WASp. Int. J. Biochem. Cell Biol. 34, 806–815.
Kim, A.S., Kakalis, L.T., Abdul-Manan, N., Liu, G.A.,
Rosen, M.K., 2000. Autoinhibition and activation mechan-
isms of the Wiskott–Aldrich syndrome protein. Nature 404,
151–158.
ARTICLE IN PRESS
G. Bouma et al. / Immunobiology 214 (2009) 778–790788Klein, C., Nguyen, D., Liu, C.H., Mizoguchi, A., Bhan, A.K.,
Miki, H., Takenawa, T., Rosen, F.S., Alt, F.W., Mulligan,
R.C., Snapper, S.B., 2003. Gene therapy for Wiskott–
Aldrich syndrome: rescue of T-cell signaling and amelioration
of colitis upon transplantation of retrovirally transduced
hematopoietic stem cells in mice. Blood 101, 2159–2166.
Krawczyk, C., Oliveira-dos-Santos, A., Sasaki, T., Grifﬁths,
E., Ohashi, P.S., Snapper, S., Alt, F., Penninger, J.M.,
2002. Vav1 controls integrin clustering and MHC/peptide-
speciﬁc cell adhesion to antigen-presenting cells. Immunity
16, 331–343.
Lee, K.H., Dinner, A.R., Tu, C., Campi, G., Raychaudhuri,
S., Varma, R., Sims, T.N., Burack, W.R., Wu, H., Wang,
J., Kanagawa, O., Markiewicz, M., Allen, P.M., Dustin,
M.L., Chakraborty, A.K., Shaw, A.S., 2003. The immu-
nological synapse balances T cell receptor signaling and
degradation. Science 302, 1218–1222.
Leverrier, Y., Lorenzi, R., Blundell, M.P., Brickell, P.,
Kinnon, C., Ridley, A.J., Thrasher, A.J., 2001. Cutting
edge: the Wiskott–Aldrich syndrome protein is required for
efﬁcient phagocytosis of apoptotic cells. J. Immunol. 166,
4831–4834.
Lim, R.P., Misra, A., Wu, Z., Thanabalu, T., 2007. Analysis of
conformational changes in WASP using a split YFP.
Biochem. Biophys. Res. Commun. 362, 1085–1089.
Linder, S., Kopp, P., 2005. Podosomes at a glance. J. Cell Sci.
118, 2079–2082.
Linder, S., Nelson, D., Weiss, M., Aepfelbacher, M., 1999.
Wiskott–Aldrich syndrome protein regulates podosomes in
primary human macrophages. Proc. Natl. Acad. Sci. USA
96, 9648–9653.
Lorenzi, R., Brickell, P.M., Katz, D.R., Kinnon, C., Thrasher,
A.J., 2000. Wiskott–Aldrich syndrome protein is necessary
for efﬁcient IgG-mediated phagocytosis. Blood 95,
2943–2946.
Maillard, M.H., Cotta-de-Almeida, V., Takeshima, F.,
Nguyen, D.D., Michetti, P., Nagler, C., Bhan, A.K.,
Snapper, S.B., 2007. The Wiskott–Aldrich syndrome
protein is required for the function of CD4(+)CD25(+)
Foxp3(+) regulatory T cells. J. Exp. Med. 204, 381–391.
Marangoni, F., Trifari, S., Scaramuzza, S., Panaroni, C.,
Martino, S., Notarangelo, L.D., Baz, Z., Metin, A.,
Cattaneo, F., Villa, A., Aiuti, A., Battaglia, M., Roncarolo,
M.G., Dupre, L., 2007. WASP regulates suppressor activity
of human and murine CD4(+)CD25(+)FOXP3(+) nat-
ural regulatory T cells. J. Exp. Med. 204, 369–380.
Martin, F., Toscano, M.G., Blundell, M., Frecha, C.,
Srivastava, G.K., Santamaria, M., Thrasher, A.J., Molina,
I.J., 2005. Lentiviral vectors transcriptionally targeted to
hematopoietic cells by WASP gene proximal promoter
sequences. Gene Ther. 12, 715–723.
Messina, C., Kirkpatrick, D., Fitzgerald, P.A., O’Reilly, R.J.,
Siegal, F.P., Cunningham-Rundles, C., Blaese, M., Oleske,
J., Pahwa, S., Lopez, C., 1986. Natural killer cell function
and interferon generation in patients with primary im-
munodeﬁciencies. Clin. Immunol. Immunopathol. 39,
394–404.
Meyer-Bahlburg, A., Becker-Herman, S., Humblet-Baron, S.,
Khim, S., Weber, M., Bouma, G., Thrasher, A.J., Batista,
F.D., Rawlings, D.J., 2008. Wiskott–Aldrich syndromeprotein deﬁciency in B cells results in impaired peripheral
homeostasis. Blood 112, 4158–4169.
Millard, T.H., Sharp, S.J., Machesky, L.M., 2004. Signalling
to actin assembly via the WASP (Wiskott–Aldrich syn-
drome protein)-family proteins and the Arp2/3 complex.
Biochem. J. 380, 1–17.
Molina, I.J., Kenney, D.M., Rosen, F.S., Remold-O’Donnell,
E., 1992. T cell lines characterize events in the pathogenesis
of the Wiskott–Aldrich syndrome. J. Exp. Med. 176,
867–874.
Molina, I.J., Sancho, J., Terhorst, C., Rosen, F.S., Remold-
O’Donnell, E., 1993. T cells of patients with the Wiskott–
Aldrich syndrome have a restricted defect in proliferative
responses. J. Immunol. 151, 4383–4390.
Monks, C.R., Freiberg, B.A., Kupfer, H., Sciaky, N., Kupfer,
A., 1998. Three-dimensional segregation of supramolecular
activation clusters in T cells. Nature 395, 82–86.
Morales-Tirado, V., Johannson, S., Hanson, E., Howell, A.,
Zhang, J., Siminovitch, K.A., Fowell, D.J., 2004. Cutting
edge: selective requirement for the Wiskott–Aldrich syn-
drome protein in cytokine, but not chemokine, secretion by
CD4+ T cells. J. Immunol. 173, 726–730.
Moulding, D.A., Blundell, M.P., Spiller, D.G., White, M.R.,
Cory, G.O., Calle, Y., Kempski, H., Sinclair, J., Ancliff,
P.J., Kinnon, C., Jones, G.E., Thrasher, A.J., 2007.
Unregulated actin polymerization by WASp causes defects
of mitosis and cytokinesis in X-linked neutropenia. J. Exp.
Med. 204, 2213–2224.
Nguyen, D.D., Maillard, M.H., Cotta-de-Almeida, V., Mizo-
guchi, E., Klein, C., Fuss, I., Nagler, C., Mizoguchi, A.,
Bhan, A.K., Snapper, S.B., 2007. Lymphocyte-dependent
and Th2 cytokine-associated colitis in mice deﬁcient in
Wiskott–Aldrich syndrome protein. Gastroenterology 133,
1188–1197.
Notarangelo, L.D., Notarangelo, L.D., Ochs, H.D., 2005.
WASP and the phenotypic range associated with deﬁciency.
Curr. Opin. Allergy Clin. Immunol. 5, 485–490.
Ochs, H.D., Slichter, S.J., Harker, L.A., Von Behrens, W.E.,
Clark, R.A., Wedgwood, R.J., 1980. The Wiskott–Aldrich
syndrome: studies of lymphocytes, granulocytes, and
platelets. Blood 55, 243–252.
Ochs, H.D., Thrasher, A.J., 2006. The Wiskott–Aldrich
syndrome. J. Allergy Clin. Immunol. 117, 725–738.
Oda, A., Ochs, H.D., Druker, B.J., Ozaki, K., Watanabe, C.,
Handa, M., Miyakawa, Y., Ikeda, Y., 1998. Collagen
induces tyrosine phosphorylation of Wiskott–
Aldrich syndrome protein in human platelets. Blood 92,
1852–1858.
Olivier, A., Jeanson-Leh, L., Bouma, G., Compagno, D.,
Blondeau, J., Seye, K., Charrier, S., Burns, S., Thrasher,
A.J., Danos, O., Vainchenker, W., Galy, A., 2006. A partial
down-regulation of WASP is sufﬁcient to inhibit podosome
formation in dendritic cells. Mol. Ther. 13, 729–737.
Orange, J.S., Ramesh, N., Remold-O’Donnell, E., Sasahara,
Y., Koopman, L., Byrne, M., Bonilla, F.A., Rosen, F.S.,
Geha, R.S., Strominger, J.L., 2002. Wiskott–Aldrich
syndrome protein is required for NK cell cytotoxicity
and colocalizes with actin to NK cell-activating immuno-
logic synapses. Proc. Natl. Acad. Sci. USA 99,
11351–11356.
ARTICLE IN PRESS
G. Bouma et al. / Immunobiology 214 (2009) 778–790 789Park, J.Y., Kob, M., Prodeus, A.P., Rosen, F.S., Shcherbina,
A., Remold-O’Donnell, E., 2004. Early deﬁcit of lympho-
cytes in Wiskott–Aldrich syndrome: possible role of WASP
in human lymphocyte maturation. Clin. Exp. Immunol.
136, 104–110.
Park, J.Y., Shcherbina, A., Rosen, F.S., Prodeus, A.P.,
Remold-O’Donnell, E., 2005. Phenotypic perturbation of
B cells in the Wiskott–Aldrich syndrome. Clin. Exp.
Immunol. 139, 297–305.
Pulecio, J., Tagliani, E., Scholer, A., Prete, F., Fetler, L.,
Burrone, O.R., Benvenuti, F., 2008. Expression of Wiskott–
Aldrich syndrome protein in dendritic cells regulates
synapse formation and activation of naive CD8+ T cells.
J. Immunol. 181, 1135–1142.
Sasahara, Y., Rachid, R., Byrne, M.J., de la Fuente, M.A.,
Abraham, R.T., Ramesh, N., Geha, R.S., 2002. Mechanism of
recruitment of WASP to the immunological synapse and of its
activation following TCR ligation. Mol. Cell 10, 1269–1281.
Shcherbina, A., Rosen, F.S., Remold-O’Donnell, E., 1999.
WASP levels in platelets and lymphocytes of Wiskott–
Aldrich syndrome patients correlate with cell dysfunction.
J. Immunol. 163, 6314–6320.
Sims, T.N., Soos, T.J., Xenias, H.S., Dubin-Thaler, B.,
Hofman, J.M., Waite, J.C., Cameron, T.O., Thomas,
V.K., Varma, R., Wiggins, C.H., Sheetz, M.P., Littman,
D.R., Dustin, M.L., 2007. Opposing effects of PKCtheta
and WASp on symmetry breaking and relocation of the
immunological synapse. Cell 129, 773–785.
Snapper, S.B., Meelu, P., Nguyen, D., Stockton, B.M., Bozza,
P., Alt, F.W., Rosen, F.S., von Andrian, U.H., Klein, C.,
2005. WASP deﬁciency leads to global defects of directed
leukocyte migration in vitro and in vivo. J. Leukoc. Biol.
77, 993–998.
Snapper, S.B., Rosen, F.S., Mizoguchi, E., Cohen, P., Khan,
W., Liu, C.H., Hagemann, T.L., Kwan, S.P., Ferrini, R.,
Davidson, L., Bhan, A.K., Alt, F.W., 1998. Wiskott–Al-
drich syndrome protein-deﬁcient mice reveal a role for
WASP in T but not B cell activation. Immunity 9, 81–91.
Strom, T.S., Gabbard, W., Kelly, P.F., Cunningham, J.M.,
Nienhuis, A.W., 2003a. Functional correction of T cells
derived from patients with the Wiskott–Aldrich syndrome
(WAS) by transduction with an oncoretroviral vector
encoding the WAS protein. Gene Ther. 10, 803–809.
Strom, T.S., Turner, S.J., Andreansky, S., Liu, H., Doherty,
P.C., Srivastava, D.K., Cunningham, J.M., Nienhuis, A.W.,
2003b. Defects in T-cell-mediated immunity to inﬂuenza
virus in murine Wiskott–Aldrich syndrome are corrected by
oncoretroviral vector-mediated gene transfer into repopu-
lating hematopoietic cells. Blood 102, 3108–3116.
Sullivan, K.E., Mullen, C.A., Blaese, R.M., Winkelstein, J.A.,
1994. A multiinstitutional survey of the Wiskott–Aldrich
syndrome. J. Pediatr. 125, 876–885.
Swanson, J.A., 2008. Shaping cups into phagosomes and
macropinosomes. Nat. Rev. Mol. Cell Biol. 9, 639–649.
Tacke, F., Randolph, G.J., 2006. Migratory fate and
differentiation of blood monocyte subsets. Immunobiology
211, 609–618.
Takenawa, T., Suetsugu, S., 2007. The WASP–WAVE protein
network: connecting the membrane to the cytoskeleton.
Nat. Rev. Mol. Cell Biol. 8, 37–48.Thrasher, A.J., 2002. WASp in immune-system organization
and function. Nat. Rev. Immunol. 2, 635–646.
Torres, E., Rosen, M.K., 2003. Contingent phosphorylation/
dephosphorylation provides a mechanism of molecular
memory in WASP. Mol. Cell 11, 1215–1227.
Torres, E., Rosen, M.K., 2005. Protein tyrosine kinase and
GTPase signals cooperate to phosphorylate and activate
WASP/N-WASP. J. Biol. Chem. published online on 17
Nov 2005: doi:10.1074/jbc.M509416200.
Trifari, S., Sitia, G., Aiuti, A., Scaramuzza, S., Marangoni, F.,
Guidotti, L.G., Martino, S., Saracco, P., Notarangelo, L.D.,
Roncarolo, M.G., Dupre, L., 2006. Defective Th1 cytokine
gene transcription in CD4+ and CD8+ T cells fromWiskott–
Aldrich syndrome patients. J. Immunol. 177, 7451–7461.
Tsuboi, S., Meerloo, J., 2007. Wiskott–Aldrich syndrome
protein is a key regulator of the phagocytic cup formation
in macrophages. J. Biol. Chem. 282, 34194–34203.
Varma, R., Campi, G., Yokosuka, T., Saito, T., Dustin, M.L.,
2006. T cell receptor-proximal signals are sustained in
peripheral microclusters and terminated in the central
supramolecular activation cluster. Immunity 25, 117–127.
Vermi, W., Blanzuoli, L., Kraus, M.D., Grigolato, P., Donato,
F., Loffredo, G., Marino, C.E., Alberti, D., Notarangelo,
L.D., Facchetti, F., 1999. The spleen in the Wiskott–Al-
drich syndrome: histopathologic abnormalities of the white
pulp correlate with the clinical phenotype of the disease.
Am. J. Surg. Pathol. 23, 182–191.
Vicente-Manzanares, M., Sanchez-Madrid, F., 2004. Role of
the cytoskeleton during leukocyte responses. Nat. Rev.
Immunol. 4, 110–122.
Wada, T., Jagadeesh, G.J., Nelson, D.L., Candotti, F., 2002.
Retrovirus-mediated WASP gene transfer corrects Wiskott–
Aldrich syndrome T-cell dysfunction. Hum. Gene Ther. 13,
1039–1046.
Westerberg, L., Greicius, G., Snapper, S.B., Aspenstrom, P.,
Severinson, E., 2001. Cdc42, Rac1, and the Wiskott–
Aldrich syndrome protein are involved in the cytoskeletal
regulation of B lymphocytes. Blood 98, 1086–1094.
Westerberg, L., Larsson, M., Hardy, S.J., Fernandez, C.,
Thrasher, A.J., Severinson, E., 2005. Wiskott–Aldrich
syndrome protein deﬁciency leads to reduced B-cell
adhesion, migration, and homing, and a delayed humoral
immune response. Blood 105, 1144–1152.
Westerberg, L., Wallin, R.P., Greicius, G., Ljunggren, H.G.,
Severinson, E., 2003. Efﬁcient antigen presentation of soluble,
but not particulate, antigen in the absence of Wiskott–Aldrich
syndrome protein. Immunology 109, 384–391.
Westerberg, L.S., de la Fuente, M.A., Wermeling, F., Ochs,
H.D., Karlsson, M.C., Snapper, S.B., Notarangelo, L.D.,
2008. WASP confers selective advantage for speciﬁc
hematopoietic cell populations and serves a unique role in
marginal zone B-cell homeostasis and function. Blood 112,
4139–4147.
Worthylake, R.A., Burridge, K., 2001. Leukocyte transen-
dothelial migration: orchestrating the underlying molecular
machinery. Curr. Opin. Cell Biol. 13, 569–577.
Zeng, R., Cannon, J.L., Abraham, R.T., Way, M., Billadeau,
D.D., Bubeck-Wardenberg, J., Burkhardt, J.K., 2003. SLP-76
coordinates Nck-dependent Wiskott–Aldrich syndrome protein
recruitment with Vav-1/Cdc42-dependent Wiskott–Aldrich
ARTICLE IN PRESS
G. Bouma et al. / Immunobiology 214 (2009) 778–790790syndrome protein activation at the T cell-APC contact site.
J. Immunol. 171, 1360–1368.
Zhang, H., Schaff, U.Y., Green, C.E., Chen, H., Sarantos,
M.R., Hu, Y., Wara, D., Simon, S.I., Lowell, C.A., 2006.
Impaired integrin-dependent function in Wiskott–Aldrich
syndrome protein-deﬁcient murine and human neutrophils.
Immunity 25, 285–295.
Zhang, J., Shehabeldin, A., da Cruz, L.A., Butler, J., Somani,
A.K., McGavin, M., Kozieradzki, I., dos Santos, A.O.,Nagy, A., Grinstein, S., Penninger, J.M., Siminovitch,
K.A., 1999. Antigen receptor-induced activation and
cytoskeletal rearrangement are impaired in Wiskott–
Aldrich syndrome protein-deﬁcient lymphocytes. J. Exp.
Med. 190, 1329–1342.
Zicha, D., Allen, W.E., Brickell, P.M., Kinnon, C.,
Dunn, G.A., Jones, G.E., Thrasher, A.J., 1998. Chemotaxis
of macrophages is abolished in the Wiskott–Aldrich
syndrome. Br. J. Haematol. 101, 659–665.
